Compugen (CGEN) announced leadership transitions to take effect in September 2025 following the Annual General Meeting. Anat Cohen-Dayag, currently President and CEO, will assume the newly created role of Executive Chair of the Board of Directors, subject to shareholder approval. Eran Ophir, currently Chief Scientific Officer, has been appointed President and CEO and will join the Board of Directors, subject to shareholder approval. Paul Sekhri will step down as Chair of the Board of Directors. Cohen-Dayag has led Compugen as President and CEO since 2010. In her new role as Executive Chair, Cohen-Dayag will focus on Compugen’s corporate strategy, strategic collaborations, and be involved in investor relations. Ophir has served in various managerial and executive roles at Compugen for nearly a decade.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.